Tetra Radar · Company Timeline
Regeneron Pharmaceuticals Inc (REGN)
Sector: Health Care
Earlier observations
- · FDA approval. The FDA approved Pasatru to reduce new heterotopic ossification and clinician-assessed disease flare-ups in adults with fibrodysplasia ossificans progressiva.
- · FDA approval. The FDA approved OTARMENI for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any frequency >90 dB HL) associated with molecularly confirmed biallelic variants in the OTOF gene, preserved outer hair cell function, an…
Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.
Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.